In addition, our observation of significantly increased CD31 immunostaining with the addition of ACVR1 R206H to the PDGF-A; p53 loss driven glioma model is also consistent with the mesenchymal subtype that is characterized by increased angiogenesis. This evidence concerns the gene PDGFA and central nervous system cancer.